Outcome Prediction in Pneumonia Induced ALI/ARDS by Clinical Features and Peptide Patterns of BALF Determined by Mass Spectrometry

Abstract

BackgroundPeptide patterns of bronchoalveolar lavage fluid (BALF) were assumed to reflect the complex pathology of acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) better than clinical and inflammatory parameters and may be superior for outcome prediction.Methodology/Principal FindingsA training group of patients suffering from ALI/ARDS was compiled from equal numbers of survivors and nonsurvivors. Clinical history, ventilation parameters, Murray's lung injury severity score (Murray's LISS) and interleukins in BALF were gathered. In addition, samples of bronchoalveolar lavage fluid were analyzed by means of hydrophobic chromatography and MALDI-ToF mass spectrometry (MALDI-ToF MS).Receiver operating characteristic (ROC) analysis for each clinical and cytokine parameter revealed interleukin-6>interleukin-8>diabetes mellitus>Murray's LISS as the best outcome predictors. Outcome predicted on the basis of BALF levels of interleukin-6 resulted in 79.4% accuracy, 82.7% sensitivity and 76.1% specificity (area under the ROC curve, AUC, 0.853). Both clinical parameters and cytokines as well as peptide patterns determined by MALDI-ToF MS were analyzed by classification and regression tree (CART) analysis and support vector machine (SVM) algorithms. CART analysis including Murray's LISS, interleukin-6 and interleukin-8 in combination was correct in 78.0%. MALDI-ToF MS of BALF peptides did not reveal a single identifiable biomarker for ARDS. However, classification of patients was successfully achieved based on the entire peptide pattern analyzed using SVM. This method resulted in 90% accuracy, 93.3% sensitivity and 86.7% specificity following a 10-fold cross validation (AUC = 0.953). Subsequent validation of the optimized SVM algorithm with a test group of patients with unknown prognosis yielded 87.5% accuracy, 83.3% sensitivity and 90.0% specificity.Conclusions/SignificanceMALDI-ToF MS peptide patterns of BALF, evaluated by appropriate mathematical methods can be of value in predicting outcome in pneumonia induced ALI/ARDS.

Annexin A2 contributes to lung injury and fibrosis by augmenting factor Xa fibrogenic activity

“…IL-6 is a fibrogenic cytokine that signals through glycoprotein 130 (gp130) and is implicated in pulmonary fibrosis (23). IL-6 levels in serum and BALF of patients with ARDS and ILDs are elevated, being predictive of lung function decline and mortality (10,15,28,50). IL-6 immunoreactivity is also associated with fibroblasts in lung tissue of IPF patients (1,38).…”

Bioinformatics insights into acute lung injury/acute respiratory distress syndrome

“…It is an emerging component of the systems biology approach for the discovery of clinically relevant biomarkers and potential therapeutic targets [23]. The most often applied technology is nuclear magnetic resonance (NMR) and mass spectrometry [24][25][26]. Since NMR spectrometry can identify and quantify multiple metabolites from a single liquid or solid sample and it's cost effective and robust, it proved to be very useful in metabolomics studies.…”

The top 2,000 cited articles in critical care medicine: a bibliometric analysis

“…Elderly patients typically have multiple comorbidities and an acute illness such as pneumonia, myocardial infarction, or sepsis that may cause acute decompensation or a new critical illness requiring intensive care unit (ICU) admission (1,2). For example, myocardial infarction could cause cardiogenic shock and acute hypoxic respiratory failure (3).…”